King Pharmaceuticals - Wikipedia
King Pharmaceuticals, Inc. is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company .
Pfizer to Acquire King Pharmaceuticals, Inc.
Oct 11, 2010 · Under the terms of the agreement, Pfizer will acquire King, a diversified specialty pharmaceutical discovery and clinical development company, for $3.6 billion in cash, or $14.25 per share, which represents a premium of approximately 40% to King's closing price as of …
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Feb 28, 2011 · (BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it has combined operations with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp., with and into King.
King Pharmaceuticals, Inc. -- Company History
King Pharmaceuticals, Inc. is a Bristol, Tennessee, company that has leveraged its position as a contract manufacturer of drugs to become a significant niche player in the pharmaceutical industry. Rather than investing in research and development, the family-run, public company has built up a portfolio of some 50 products by acquiring brand ...
Pfizer to Acquire King Pharmaceuticals, Inc. | Fierce Pharma
Oct 12, 2010 · Under the terms of the agreement, Pfizer will acquire King, a diversified specialty pharmaceutical discovery and clinical development company, for $3.6 billion in cash, or $14.25 per share,...
King Pharmaceuticals - LinkedIn
King, an S&P 500 Index company, is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in specialty-driven...
Pfizer sells King Pharma plant to UPM Pharmaceuticals
May 30, 2013 · The Baltimore, MD-based contract developer and manufacturer UPM Pharmaceuticals is buying the 500,000-square-foot plant in Bristol, TN, that Pfizer acquired in its $3.6 billion purchase of King...
Pfizer to buy King Pharma for $3.6 billion in cash | Reuters
Oct 12, 2010 · Pfizer Inc, the world's largest drugmaker, has agreed to buy King Pharmaceuticals Inc for $3.6 billion in a move to shore up earnings ahead of the looming evaporation of revenue from Lipitor,...
Pfizer buys King Pharmaceuticals for $3.6 billion
Oct 12, 2010 · Known primarily for its tamper-resistant formulations of opioid analgesics, King Pharmaceuticals will expand Pfizer's portfolio in the pain category, adding King's Embeda, Avinza and Flector Patch to Pfizer's Lyrica and Celebrex products.
King Pharmaceuticals Careers and Employment | Indeed.com
Aug 7, 2020 · King Pharmaceuticals, is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by Pfizer for $14.25 per share.